RAPT Therapeutics Q2 EPS $(0.66) Down From $(0.62) YoY
Portfolio Pulse from Happy Mohamed
RAPT Therapeutics reported Q2 losses of $(0.66) per share, a 6.45% decrease from the same period last year.
August 11, 2023 | 12:09 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
RAPT Therapeutics reported a 6.45% increase in losses per share in Q2 YoY.
RAPT Therapeutics reported a 6.45% increase in losses per share for Q2 compared to the same period last year. This is a negative financial performance indicator, which could lead to a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100